PerkinElmer, Inc. (NYSE:PKI) Files An 8-K Results of Operations and Financial ConditionItem 2.02.Results of Operations and Financial Condition
|
(d) |
Exhibits |
|
The following exhibit relating to Item 2.02 shall be deemed to be furnished, and not filed: |
|
|
99.1Press Release entitled “PerkinElmer Announces Financial Results for the Second Quarter of 2017”, issued by PerkinElmer, Inc. on August 3, 2017. |
PERKINELMER INC ExhibitEX-99.1 2 a51604260ex99_1.htm EXHIBIT 99.1 Exhibit 99.1 PerkinElmer Announces Financial Results for the Second Quarter of 2017 GAAP and adjusted revenues of $547 million GAAP earnings per share from continuing operations of $0.57; Adjusted earnings per share of $0.67 GAAP operating margins expand by 150 basis points; Adjusted operating margins expand by 70 basis points Raises full year guidance WALTHAM,…To view the full exhibit click here
About PerkinElmer, Inc. (NYSE:PKI)
PerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental and laboratory markets. The Company’s operating segments include Human Health, Environmental Health and Corporate. The Human Health segment concentrates on developing diagnostics, tools and applications to help detect diseases earlier. Within its Human Health segment, the Company serves the diagnostics and research markets. It provides early detection for genetic disorders from pregnancy to early childhood, as well as flat panel X-ray detectors and infectious disease testing for the diagnostics market. The Environmental Health segment provides products, services and solutions to facilitate the creation of safer food and consumer products, secure surroundings and energy resources. The Environmental Health segment serves the environmental, industrial and laboratory services markets. The Company markets its products and services in over 150 countries.
